(Q34441322)

2 August 2017

title

Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice (English)

1 reference

2 August 2017

0 references

0 references

Mary F Divin

1

1 reference

2 August 2017

M C Holden Ko

series ordinal

2

1 reference

2 August 2017

John R Traynor

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

24 January 2008

1 reference

European Journal of Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

583

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

48-55

1 reference

Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Some quantitative uses of drug antagonists

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Differentiation of kappa opioid agonist-induced antinociception by naltrexone apparent pA2 analysis in rhesus monkeys

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Clinical pharmacokinetics of narcotic agonist-antagonist drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Substitution and primary dependence studies in animals.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Narcotic antagonist activity of several metabolites of naloxone and naltrexone tested in morphine dependent mice (38558)

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Butorphanol-mediated antinociception in mice: partial agonist effects and mu receptor involvement.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Synthesis and opioid receptor affinity of a series of aralkyl ethers of 6 alpha- and 6 beta-naltrexol

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Characterization of prototypical opioid antagonists, agonist-antagonists, and agonists in the morphine-dependent rhesus monkey

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3010382

Serum time course of naltrexone and 6β-naltrexol levels during long term treatment in drug addicts

27 October 2018

1 reference

12 December 2020

Influence of different benzodiazepines on the experimental morphine abstinence syndrome

1 reference

12 December 2020

The effects of neurotensin, naloxone and haloperidol on elements of excessive grooming behavior induced by bombesin

1 reference

12 December 2020

Stereospecific synthesis of the 6.beta.-hydroxy metabolites of naltrexone and naloxone

1 reference

12 December 2020

Development of physical dependence on morphine in respect to time and dosage and quantification of the precipitated withdrawal syndrome in rats

1 reference

12 December 2020

10.1016/J.EJPHAR.2008.01.004

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference